A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407-Reference-Cited by-同舟云学术

A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

Published:2020-10 Issue:10 Volume:15 Page:1657-1669
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Paz-Ares Luis,Vicente David,Tafreshi Ali,Robinson Andrew,Soto Parra Hector,Mazières Julien,Hermes Barbara,Cicin Irfan,Medgyasszay Balazs,Rodríguez-Cid Jerónimo,Okamoto Isamu,Lee SungSook,Ramlau Rodryg,Vladimirov Vladimir,Cheng Ying,Deng Xuan,Zhang Ying,Bas Tuba,Piperdi Bilal,Halmos Balazs

Funder

Merck Sharp and Dohme

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference21 articles.

1. Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?;Apetoh;Ann Oncol,2015

2. Metastatic squamous cell non-small-cell lung cancer (NSCLC): disrupting the drug treatment paradigm with immunotherapies;Scarpace;Drugs Context,2015

3. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019

4. Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater;Reck;J Clin Oncol,2019

5. Exploiting the immunomodulatory properties of chemotherapeutic drugs to improve the success of cancer immunotherapy;Kersten;Front Immunol,2015

Cited by 456 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review;International Immunopharmacology;2024-11

2. Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer;Translational Research;2024-10

3. Impact of baseline steroids on the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma;World Journal of Gastrointestinal Oncology;2024-09-15

4. Clinical multi-dimensional prognostic nomogram for predicting the efficacy of immunotherapy in NSCLC;Scientific Reports;2024-09-13

5. Integrating radiomics and real-world data to predict immune-checkpoint inhibitors efficacy in advanced Non-Small Cell Lung Cancer;2024-09-02